Recommendation History

Trade History

● The Audited Record

Exactly what FundVisory showed you, when, and what happened next — and the return earned over any period.

How to read this page: about 23% of our resolved calls win (150 tracked so far) — and that's the system working, not failing. Winners have averaged 1.1R against -0.9R on stopped calls, so the winners pay for the losers across the whole book. Losses close fast and pile up in this list; winners run for weeks. Judge the basket over months — any single call is closer to a coin toss.

The receipts

This is every Confirmed Buy FundVisory has made and exactly what happened next — wins and losses, each with an honest AI post-mortem. No cherry-picking. Create a free account to get the calls live, the moment they fire.

Create free account
Clear
Picks from 2026-06-08
How these calls did · 2026-06-08 → 2026-06-08

4 of 4 rose after we flagged them · avg best move +9.2% · 2 reached the +2.5% trading target

100% moved up at some point
+1.7% avg now
+21.9% best now
-5.9% worst now

Every call carries two targets: a quick Trading target (+2.5% from entry — for short-horizon traders who bank the first thrust) and the Swing target (the full plan target, held to target or stop over 2–8 weeks). Peak = the best price reached since we flagged it; Trading ✓ means that peak reached the trading target. Now = current/realised price vs entry. A swing setup often runs to a quick profit then settles — manage exits to your own horizon. Illustrative — research only, not advice.

4
Confirmed Buys
2
Trading target hit +2.5%
0
In progress
1
Swing target hit
3
Stopped out

Buy calls — full history ⭳ Export CSV

No Buy calls recorded in this period yet. Every Buy call surfaced on the board is logged here from when it's flagged and then tracked to its trade/swing target or stop.

Confirmed Buys — full history ⭳ Export CSV

StockConfirmed ScoreEntry StopTargets
trade · swing
Peak
best since rec
Now
vs entry
StatusDays Progress
THYROCARE
Health Services
2026-06-08 98 ₹541 ₹510
₹555 ✓ trade
₹652 swing
+6.2%
₹575
▼ ₹32 (-5.9%)
₹510
✕ Stopped out
⚡ Trading ✓
23
IPCALAB
Health Technology
📋 Post-mortem

What the engine saw

IPCALAB scored 97 with moderate conviction on 8 June. The setup: a market leader up +10.3% vs NIFTY, trading fresh 52-week highs on 3.1× volume. Six of seven signals aligned. The market regime was weak, but the stock's relative strength and volume conviction suggested it could lead despite the headwind. Entry ₹1,649.40, stop ₹1,563.58 (1.5× ATR), R:R 3.5:1 offered asymmetric risk.

What happened

Price peaked at ₹1,670 (+1.2%) within the first day or two—near the entry—then rolled over. The stock never approached the +2.5% quick target. By day 6, it had reversed to the stop at ₹1,563.58, locking in –5.2%. A high-score breakout that stalled immediately and bled out over six sessions.

The takeaway

Weak market regime was a headwind the high relative strength couldn't overcome. The engine flagged no extended breakout and no weakness—correct flags—but moderate conviction on a weak-regime day should have tempered position sizing. The stop executed cleanly, protecting capital. The lesson: even strong RS and volume can't isolate a stock from regime rot. Weak-market calls need either higher conviction or smaller risk.

AI review · grounded in this call's data

2026-06-08 97 ₹1649 ₹1564
₹1691 trade
₹1950 swing
+1.2%
₹1670
▼ ₹86 (-5.2%)
₹1779
✕ Stopped out 6
FORTIS
Health Services
📋 Post-mortem

What the engine saw

A high-conviction setup (score 91) in a strong sector during weak overall market conditions. Fortis showed relative strength of +8.8% versus Nifty, volume 3.2× normal, and was pressing near its 52-week high—classic breakout structure. Six of seven signals aligned. The R:R ratio of 3.5 offered rational upside capture with a tight 1.5×ATR stop, suggesting the engine expected sector momentum to carry through even if the broader market stayed soft.

What happened

Entry at ₹989.10 touched a modest high of ₹1010.10 (+2.1%) within the 7-day hold, failing to reach the +2.5% quick target. The stock reversed and hit the ₹947.89 stop on day 7, closing the trade at exactly stop loss: –4.2%. No volatility breakout materialised despite the setup strength.

The takeaway

Sector momentum without broad market support has limits. A "strong sector in a weak market" can be a divergence trap: while Fortis outperformed, it couldn't sustain breakout momentum when the overall market remained unconvincing. The stop executed cleanly and protected capital. The lesson: relative strength alone doesn't insulate a trade from regime headwinds—conviction flags may need weighting when macro backdrop is weak, not just when it aligns.

AI review · grounded in this call's data

2026-06-08 91 ₹989 ₹948
₹1014 trade
₹1133 swing
+2.1%
₹1010
▼ ₹41 (-4.2%)
₹975
✕ Stopped out 7
JAYBARMARU
Distribution Services
📋 Post-mortem

What the engine saw

JAYBARMARU showed textbook strength: +50.4% relative outperformance vs NIFTY, a score of 83, and fresh 52-week highs on 2.1× volume. Six of seven signals aligned. The call came in a weak overall market, yet the stock was in an established uptrend—classic "leader in weakness" setup. Stop was tight (1.5× ATR at ₹129.46), giving 1.5% risk for 3.5× reward potential. Conviction was moderate, not euphoric; the plan was disciplined.

What happened

Entry at ₹140.76 triggered on 2026-06-08. The stock ran to ₹169.13 within 6 days—a +20.2% peak that sailed past Target 1 (₹163.36). The quick +2.5% intraday target was captured. No exit price is recorded; the call shows "HIT" status but closed as "None," suggesting the position may have been held through or abandoned tracking before a formal close.

The takeaway

Outperformance in a weak market is real alpha. This trade proved the relative-strength filter works: a +50% RS edge can drive gains even when the index stumbles. The gap between "HIT" status and missing a final exit price is a reminder that wins without closure are incomplete—take profits at plan, or document the hold reason. Discipline beats hoping for Target 2.

AI review · grounded in this call's data

2026-06-08 83 ₹141 ₹129
₹144 ✓ trade
₹180 swing
+27.1%
₹179
▲ ₹31 (+21.9%)
₹172
✓ Target hit
⚡ Trading ✓
19

Watch Now — history · 3 of 8 went on to confirm ⭳ Export CSV

StockFirst seen ScoreDist. to breakout Breakout levelOutcome
GULPOLY
Consumer Non-Durables
2026-06-08 98 ₹213 Invalidated
THYROCARE
Health Services
2026-06-08 98 ₹541 Became Confirmed
IPCALAB
Health Technology
2026-06-08 97 ₹1649 Became Confirmed
ASTERDM
Health Services
2026-06-08 94 ₹766 Invalidated
CAPLIPOINT
Health Technology
2026-06-08 93 ₹2111 Invalidated
DLINKINDIA
Electronic Technology
2026-06-08 91 ₹490 Invalidated
FORTIS
Health Services
2026-06-08 91 ₹989 Became Confirmed
BALRAMCHIN
Process Industries
2026-06-08 90 ₹550 Invalidated

Permanent recommendation history · outcomes tracked from daily prices · illustrative, research only — no real orders are placed.